Asymptomatic hypothyroidism and statin-induced myopathy.
Bar
Simona L
SL
Division of Cardiac Surgery, Vancouver General Hospital, British Columbia.
Holmes
Daniel T
DT
Frohlich
Jiri
J
D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005464:Fluorobenzenes / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000175:diagnosis / Q000188:drug therapy*; D007037:Hypothyroidism / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced* / Q000503:physiopathology; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D000068718:Rosuvastatin Calcium; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000627:therapeutic use
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D013972:Thyrotropin